<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://wiki.warofgalaxy.eu/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="de">
		<id>http://wiki.warofgalaxy.eu/index.php?action=history&amp;feed=atom&amp;title=Alimta_price9928400</id>
		<title>Alimta price9928400 - Versionsgeschichte</title>
		<link rel="self" type="application/atom+xml" href="http://wiki.warofgalaxy.eu/index.php?action=history&amp;feed=atom&amp;title=Alimta_price9928400"/>
		<link rel="alternate" type="text/html" href="http://wiki.warofgalaxy.eu/index.php?title=Alimta_price9928400&amp;action=history"/>
		<updated>2026-04-04T15:26:23Z</updated>
		<subtitle>Versionsgeschichte dieser Seite in War Of Galaxy</subtitle>
		<generator>MediaWiki 1.21.1</generator>

	<entry>
		<id>http://wiki.warofgalaxy.eu/index.php?title=Alimta_price9928400&amp;diff=2552&amp;oldid=prev</id>
		<title>SolomonbvgxrztyzhHildago: Die Seite wurde neu angelegt: „Pleural mesothelioma patients treated with both cisplatin and raltitrexed may survive longer than patients who receive cisplatin alone, according to a recent …“</title>
		<link rel="alternate" type="text/html" href="http://wiki.warofgalaxy.eu/index.php?title=Alimta_price9928400&amp;diff=2552&amp;oldid=prev"/>
				<updated>2012-10-14T13:18:58Z</updated>
		
		<summary type="html">&lt;p&gt;Die Seite wurde neu angelegt: „Pleural mesothelioma patients treated with both cisplatin and raltitrexed may survive longer than patients who receive cisplatin alone, according to a recent …“&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Neue Seite&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pleural mesothelioma patients treated with both cisplatin and raltitrexed may survive longer than patients who receive cisplatin alone, according to a recent &lt;br /&gt;
study conducted in Europe and Canada (J Clin Oncol. 2005 Oct 1; 23(28): 68819). Raltitrexed (Tomudex) works by interfering with the ability of tumor cells to &lt;br /&gt;
multiply and make deoxyribonucleic acid or DNA. Cisplatin is a traditional chemotherapy drug.&lt;br /&gt;
&lt;br /&gt;
Two hundred fifty pleural mesothelioma patients took part in a clinical trial to determine the safety and effectiveness of raltitrexed. One hundred &lt;br /&gt;
twentyfour patients took cisplatin and the rest took cisplatin plus raltitrexed. Most were men with an average age of 58 who had not received other &lt;br /&gt;
chemotherapy treatments.&lt;br /&gt;
&lt;br /&gt;
The raltitrexed study was a phase III clinical trial, as defined by the European Organization for Research and Treatment of Cancer. A phase III trial &lt;br /&gt;
compares a new cancer treatment with a standard treatment, and requires a large number of participants. It follows a phase II clinical trial, which is &lt;br /&gt;
concerned with the safety of a new treatment and how to administer it, and a basic phase I clinical trial, which tests the drugs effectiveness on a small &lt;br /&gt;
number of patients.&lt;br /&gt;
&lt;br /&gt;
Survival Increased in Patients Treated with Raltitrexed &lt;br /&gt;
The researchers looked at survival, progression of pleural mesothelioma, safety, tumor response rates, and the patients quality of life. They found the &lt;br /&gt;
following:&lt;br /&gt;
[http://www.avastina.com tarceva]&lt;/div&gt;</summary>
		<author><name>SolomonbvgxrztyzhHildago</name></author>	</entry>

	</feed>